CBA
CHRS icon

Coastal Bridge Advisors’s Coherus Oncology CHRS Stock Holding History

Coastal Bridge Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$37.4K – 178
2023
Q3 		$37.4K Buy
+10,000
New +$46.2K 0.01% 163

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coastal Bridge Advisors's CHRS Position: Q4 2023 in Review

Coastal Bridge Advisors sold out of Coherus Oncology (CHRS) in Q4 2023, closing a stake of 10,000 shares — an estimated $37.4K sold.

Coastal Bridge Advisors first reported a position in CHRS in Q3 2023 and held it in 1 quarter. The position peaked at $37.4K in Q3 2023. 156 funds tracked by Wall St. Rank hold CHRS as of Q4 2023.

  • Coastal Bridge Advisors reported no remaining Coherus Oncology position as of Q4 2023 after selling out during the quarter.
  • Coastal Bridge Advisors sold 10,000 Coherus Oncology shares in Q4 2023, an estimated $37.4K.
  • Coastal Bridge Advisors first reported a position in Coherus Oncology in Q3 2023 and held it in 1 quarter.
  • Coastal Bridge Advisors's Coherus Oncology position peaked at $37.4K in Q3 2023.
  • 156 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2023.

Based on Coastal Bridge Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.